Back to top

medical: Archive

Zacks Equity Research

4 Stocks to Ride on the CBD-Infused Beverage Trend

CBD-infused drinks are gaining fast popularity among all age groups, thanks to its many health benefits.

SAM BUD STZ TLRY APHA

Zacks Equity Research

Walgreens' Retail Pharmacy Stays Firm Amid Reimbursement Woes

Walgreens' (WBA) Retail Pharmacy USA division is witnessing comparable prescription growth and also gaining traction from a solid retail prescription market.

GWPH BAX WBA NTRP

Zacks Equity Research

MEDNAX Teams Up With CENTA to Expand Services in Florida

MEDNAX (MD) inks a partnership deal with CENTA to strengthen its profile of varied healthcare solutions in Florida.

MOH MD UHS ENSG

Zacks Equity Research

Cumberland Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy?

Cumberland Pharmaceuticals has been struggling lately, but the selling pressure may be coming to an end soon.

CPIX

Urmimala Biswas

IoMT Becomes the Buzzword in New Age MedTech Investing

Increasing adoption of cloud platforms, phones, phablets, tablets and other smart devices as well as apps is making acceptance of IoMT easier among the masses.

AAPL MDT BSX DXCM

Zacks Equity Research

CryoLife Enters Agreement With Endospan for Aortic Stent

CryoLife (CRY) eyes to expand the portfolio of aortic care, with endovascular stent graft system.

CRY BAX GWPH NTRP

Trina Mukherjee

3D Printing Gaining Popularity: 3 MedTech Stocks to Watch

In the near future, there is a probability of 3D-printed implantable organs becoming a reality, thereby increasing the number of lives saved.

SSYS OFIX MDT SYK

Zacks Equity Research

REGENXBIO (RGNX) Catches Eye: Stock Jumps 5.8%

REGENXBIO (RGNX) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

AMGN RGNX

Zacks Equity Research

Implied Volatility Surging for Catalyst (CPRX) Stock Options

Investors need to pay close attention to Catalyst (CPRX) stock based on the movements in the options market lately.

CPRX

Zacks Equity Research

Are Options Traders Betting on a Big Move in ViewRay (VRAY) Stock?

Investors need to pay close attention to ViewRay (VRAY) stock based on the movements in the options market lately.

VRAY

Zacks Equity Research

Ardelyx (ARDX) in Focus: Stock Moves 8.3% Higher

Ardelyx (ARDX) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

ARDX LCI

Zacks Equity Research

Medidata (MDSO) Collaborates With Mapi Research to Boost Rave

Medidata's (MDSO) latest collaboration is expected to solve major eCOA implementation struggles in the pharmaceutical industry.

MDSO MASI ISRG BAX

Sapna Bagaria

Hospital Industry Outlook: Rising Baby Boomers to Drive Growth

The Zacks Medical-Hospital industry is set to gain from demographic changes and growing consolidation amid high labor cost.

UHS THC HCA ACHC

Mark Vickery

Top Analyst Reports for Intel, Adobe & Mondelez

Today's Research Daily features new research reports on 16 major stocks, including Intel (INTC), Adobe Systems (ADBE) and Mondelez International (MDLZ).

XRAY MS MDLZ INTC ANET ADBE

Zacks Equity Research

Is the Options Market Predicting a Spike in CannTrust (CTST) Stock?

Investors need to pay close attention to CannTrust (CTST) stock based on the movements in the options market lately.

CTST

Zacks Equity Research

Ecolab's (ECL) Nalco Water Opens Customer Experience Center

Ecolab (ECL) expects Nalco's water technologies to reduce freshwater usage by 20%.

ECL MASI ISRG BAX

Tirthankar Chakraborty

Buffett's Best & Worst Performing Stocks Thus Far in 2019

So far this year, here are the winners and losers of Oracle of Omaha's favored companies.

KO AAPL AXP KHC BRK.B TEVA

Zacks Equity Research

Here's Why You Should Hold on to Ecolab (ECL) Stock Now

Ecolab (ECL) continues to gain from robust product portfolio and strong international presence. However, forex remains a woe.

ECL BAX AMED CNMD

Sweta Killa

Momentum ETFs & Stocks in Focus as Trump Delays Tariff Hike

While the broader stock market is expected to move higher, momentum investing will likely take charge as investors seek higher returns in a short span.

MRK ALLY ONEO PDP MTUM ZUMZ LULU KL XMMO ULVM

Zacks Equity Research

5 High-Flying Stocks Near 52-Week High That Can Scale Higher

Investors target stocks that have been on a bullish run lately. Stocks seeing price strength have a high chance of carrying the momentum forward.

BPOP SYMC MDT BAX TGT

Zacks Equity Research

Zacks Market Edge Highlights: UnitedHealth, Centene, MasTec, Bank of America and Bristol-Myers Squibb

Zacks Market Edge Highlights: UnitedHealth, Centene, MasTec, Bank of America and Bristol-Myers Squibb

BAC BMY MTZ CNC UNH

Zacks Equity Research

Bruker (BRKR) Introduces the nanoIR3-s Broadband System

The launch of the FTIR spectroscopy system complements Bruker's (BRKR) target to boost its portfolio of nanoIR products.

BRKR BAX MDT AMED

Zacks Equity Research

The Zacks Analyst Blog Highlights: Apple, Exxon, AT&T, Cardinal and ANSYS

The Zacks Analyst Blog Highlights: Apple, Exxon, AT&T, Cardinal and ANSYS

T AAPL ANSS XOM CAH

Zacks Equity Research

New Strong Sell Stocks for September 12th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

DLPH ABM AIMC ESLOY NNBR

Zacks Equity Research

What Makes Crinetics Pharmaceuticals (CRNX) a Strong Sell?

Crinetics Pharmaceuticals (CRNX) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.

FGEN CRNX